One 'oversold' ASX 200 healthcare share to buy today

After some big share price falls, is this ASX 200 healthcare stock trading for a bargain?

| More on:
Smiling couple looking at a phone at a bargain opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) healthcare share Ramsay Health Care Ltd (ASX: RHC) is in the green today following two trading days of heavy selling.

In afternoon trade on Tuesday, the Ramsay share price is up 0.5% at $40.58 a share.

That will come as welcome news to shareholders after the ASX 200 healthcare share closed down a precipitous 6.8% on Friday following the release of its full-year results.

That decline, however, looks to reinforce Shaw and Partners' Jed Richards' buy recommendation for Ramsay Health Care (courtesy of The Bull).

Why Ramsay shares could be bargain-priced

"Ramsay is Australia's biggest private hospital operator. It also operates in the UK and Europe," Richards explains.

He noted that the ASX 200 healthcare share had tumbled from $56.47 on 6 March to trade for $44.42 a share on 29 August. And shares have since declined to the current $40.58.

According to Richards:

In our view, the shares have been oversold. The company had a market capitalisation of more than $10 billion on 29 August. The company is well managed, and we expect RHC to improve in fiscal year 2025.

What's been happening with the ASX 200 healthcare share?

As mentioned up top, Ramsay reported its FY 2024 financial results on Friday, 30 August.

And those results revealed a difficult year for the private hospital operator.

While total revenue increased 9.4% year on year to $16.77 billion, earnings before interest and tax (EBIT from continuing operations) went the other direction, falling 0.4% to $998 million.

And feeling the impacts of cost inflation, the ASX 200 healthcare share reported a 2.6% decline in profit after tax from continuing operations, which came in at $271 million.

Despite the dip in profits, management pleased passive income investors with a final dividend of 40 cents per share, fully franked. That's up 60% from the prior final dividend. And it brings the full-year passive income payout to 80 cents per share.

This sees Ramsay shares trading on a fully franked dividend yield of 2.0%. And if you're looking to bag that final dividend, you'd best hurry. Ramsay shares trade ex-dividend tomorrow, 4 September. Meaning you'll need to own shares at market close today to have rights to that payout.

Eligible investors can then expect to see that passive income hit their bank account on 26 September.

Looking to the year ahead, the ASX 200 healthcare share forecasts growth in its net profit after tax from continuing operations in FY 2025. Though margin recovery is expected to be slow, impacted by ongoing inflationary pressures and investments in business enablement programs.

The Ramsay share price is down 24% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

healthcare worker overseeing group of aged care residents at table
Share Gainers

This ASX All Ords share has sneakily climbed 128% over the past year

Investors have sent this under-the-radar ASX All Ords stock flying higher. But why.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

UBS says buy CSL shares for a double-digit return in 2025

This ASX giant could create healthy returns, according to a leading broker.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

1 big factor to keep in mind before buying Pro Medicus shares

Investors would be wise to consider this metric.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

ASX All Ords share higher despite major shareholder cashing out 30% stake

Investors in this ASX All Ords healthcare share appear unperturbed by news of a major sell-down.

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development
Healthcare Shares

Up 24% in a month! This ASX biotech share is hitting a record high on trial update

The SECuRE trial is getting investors excited. Here's the latest.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

What's going on with the NIB share price today?

We now know when the private health insurer's long-serving CEO is stepping down.

Read more »

2 people using their iPhones
Healthcare Shares

Did Apple just give ResMed shares a big long-term boost?

Is awareness of sleep apnoea about to increase materially?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Are Pro Medicus shares a buy at their new all-time high?

Investors continue lifting the bid on this healthcare player.

Read more »